|
|
.
See Category: Injury, poisoning and certain other consequences of external causes
ICD-10 (CM) Code and Descriptor
|
T81.31XA |
Disruption of external operation (surgical) wound, not elsewhere classified, initial encounter
|
T8131XA utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 67.11%
|
15.59%
|
7.46%
|
3.72%
|
1.98%
|
1.08%
|
0.69%
|
0.58%
|
0.37%
|
0.25%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for T81.31XA*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
22,761
|
22,802
|
|
11042
|
DBRDMT SUBQ TIS 1ST 20SQCM/< |
18,866
|
18,944
|
|
97597
|
DBRDMT OPN WND 1ST 20 CM/< |
5,788
|
5,848
|
|
97605
|
NEG PRS WND THER DME<=50SQCM |
5,583
|
5,584
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
5,357
|
16,470
|
|
87070
|
CULTURE OTHR SPECIMN AEROBIC |
5,251
|
5,627
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
4,511
|
4,522
|
|
87205
|
SMEAR GRAM STAIN |
4,481
|
4,885
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
3,431
|
3,499
|
|
87186
|
MICROBE SUSCEPTIBLE MIC |
3,250
|
4,147
|
|
87077
|
CULTURE AEROBIC IDENTIFY |
3,116
|
4,334
|
|
J3010
|
FENTANYL CITRATE INJECTION |
2,996
|
5,117
|
|
87075
|
CULTR BACTERIA EXCEPT BLOOD |
2,788
|
3,092
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
2,755
|
11,743
|
|
80053
|
COMPREHEN METABOLIC PANEL |
2,741
|
2,742
|
|
J2405
|
ONDANSETRON HCL INJECTION |
2,595
|
11,543
|
|
11045
|
DBRDMT SUBQ TISS EACH ADDL |
2,592
|
4,295
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
2,528
|
69,578
|
|
80048
|
METABOLIC PANEL TOTAL CA |
2,420
|
2,430
|
|
G0277
|
HBOT, FULL BODY CHAMBER, 30M |
2,163
|
8,554
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
T81.31XA related to the following DRG Codes:
919-921
|
